Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Up is suddenly down in the world of aviation. And no, we’re not talking about pilot controls or making a cryptic Stranger Things reference. On Tuesday, Boeing’s CFO said the company has finally ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

Bengaluru: Meesho has pulled ahead of its consumer internet peers on free cash flow in FY25, underscoring a shift in India’s e-commerce sector from chasing growth to focusing on capital-efficient ...

A recent study revealed that almost 90% of stock market traders experience financial losses during their trading journeys. This statistic highlights the challenges and inherent risks associated with ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after the ...

Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) said Wednesday they agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion. Chart shareholders will receive 3.165 shares of Flowserve ...